Pro-opiomelanocortin processing in the hypothalamus: Impact on melanocortin signalling and obesity

Journal of Endocrinology

Volumn 172, Issue 3, 2002, Pages 411-421

  Pritchard, L E ^a   Turnbull, A V ^a   White, A ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HORMONE PRECURSOR; LIGAND; MELANOCORTIN; MELANOCORTIN 4 RECEPTOR; PEPTIDE; PROOPIOMELANOCORTIN; PROTEINASE;

CONTROLLED STUDY; ENERGY BALANCE; FOOD INTAKE; GENE CONTROL; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HUMAN; HYPOTHALAMUS; HYPOTHALAMUS FUNCTION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NERVE CELL; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN SECRETION; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; RAT; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ALPHA-MSH; ANIMALS; APPETITE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPOTHALAMUS; MUTATION; OBESITY; PRO-OPIOMELANOCORTIN; RECEPTOR, MELANOCORTIN, TYPE 4; RECEPTORS, PEPTIDE; SIGNAL TRANSDUCTION;

EID: 0036125112     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1720411     Document Type: Review

References (96)

1. Investigation of the melanocyte stimulating hormones on food intake. Lack of evidence to support a role for the melanocortin-3-receptor
2. Altered processing of pro-orphanin FQ/Nociceptin and pro-opiomelanocortin-derived peptides in the brains of mice expressing defective prohormone convertase 2
3. Anatomy of an endogenous antagonist: Relationship between agouti-related protein and proopiomelanocortin in brain
4. Genetics of body-weight regulation
5. PC1 and PC2 are proprotein convertases capable of cleaving proopiomelanocortin at distinct pairs of basic residues
6. A novel selective melanocortin-4 receptor agonist reduces food intake in rats and mice without producing aversive consequences
7. Short term starvation decreases POMC mRNA but does not alter GnRH mRNA in the brain of adult male rats
8. Subtilase-like pro-protein convertases: From molecular specificity to therapeutic applications
9. fat mice
10. Microsequencing evidence for the maturation of human proopiomelanocortin into an 18 amino acid β-melanocyte stimulating hormone [hβMSH (5-22)] in nonpituitary tissue
11. A common pro-opiomelanocortin-binding element mediates leukemia inhibitory factor and corticotropin-releasing hormone transcriptional synergy
12. Direct regulation of pituitary proopiomelanocortin by STAT3 provides a novel mechanism for immune-neuroendocrine interfacing
13. Transcriptional activation of the proopiomelanocortin gene by cyclic AMP-responsive element binding protein
14. Altered expression of hypothalamic neuropeptide mRNAs in food-restricted and food-deprived rats
15. A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse
16. Post-translational processing of proopiomelanocortin in the pituitary and in the brain
17. Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass
18. Exocrine gland dysfunction in MC5-R-deficient mice: Evidence for coordinated regulation of exocrine function by melanocortin peptides
19. Proopiomelanocortin neurons are direct targets for leptin in the hypothalamus
20. Pharmacotherapy of obesity: Targets and perspectives
21. Induction of integral membrane PAM expression in AtT-20 cells alters the storage and trafficking of POMC and PC1
22. Presence of strong glucocorticoid receptor immunoreactivity within hypothalamic and hypophyseal cells containing pro-opiomelanocortic peptides
23. Familial glucocorticoid deficiency associated with point mutation in the adrenocorticotropin receptor
24. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction
25. A major quantitative trait locus determining serum leptin levels and fat mass is located on human chromosome 2
26. The central melanocortin system and energy homeostasis
27. fat mice
28. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus
29. Transcription factor interactions: Selectors of positive or negative regulation from a single DNA element
30. Distinct mRNA expression of the highly homologous convertases PC5 and PACE4 in the rat brain and pituitary
31. Cellular localization of the prohormone convertases in the hypothalamic paraventricular and supraoptic nuclei: Selective regulation of PC1 in corticotrophin-releasing hormone parvocellular neurons mediated by glucocorticoids
32. Novel glucocorticoid receptor complex with DNA element of the hormone-repressed POMC gene
33. Characterization of proACTH/endorphin derived peptides in rat hypothalamus
34. Role of the melanocortinergic neurons in feeding and the agouti obesity syndrome
35. The melanocortin melanocyte-stimulating hormone/ adrenocorticotropin(4-10) decreases body fat in humans
36. Identification and characterisation of proSAAS, a granin-like neuroendocrine peptide precursor that inhibits prohormone processing
37. Molecular cloning, expression, and gene localization of a fourth melanocortin receptor
38. Differential release of proopiomelanocortin-derived peptides from the human pituitary: Evidence from a panel of two-site immunoradiometric assays
39. How tight are your genes?
40. Role of the CNS melanocortin system in the response to overfeeding
41. A genome-wide scan for human obesity genes reveals a major susceptibility locus on chromosome 10
42. Transcription factor STAT3 in leptin target neurons of the rat hypothalamus
43. Changes in hypothalamic agouti-related protein (AGRP), but not α-MSH or pro-opiomelanocortin concentrations in dietary-obese and food-restricted rats
44. Systematic mutation screening of the pro-opiomelanocortin gene: Identification of several genetic variants including three different insertions, one nonsense and two missense point mutations in probands of different weight extremes
45. Normal variation in leptin levels is associated with polymorphisms in the proopiomelanocortin gene, POMC
46. Targeted disruption of the melanocortin-4 receptor results in obesity in mice
47. Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene
48. Proopiomelanocortin products and human early-onset obesity
49. Melanocortin-3 receptor mRNA expression in pro-opiomelanocortin neurones of the rat arcuate nucleus
50. Differential effects of melanocortin peptides on ingestive behaviour in rats: Evidence against the involvement of MC3 receptor in the regulation of food intake
51. STZ-induced diabetes decreases and insulin normalizes POMC mRNA in arcuate nucleus and pituitary in rats
52. ARC POMC mRNA and PVN α-MSH are lower in obese relative to lean Zucker rats
53. Regulation of hypothalamic proopiomelanocortin by leptin in lean and obese rats
54. Implications of proopiomelanocortin (POMC) mutations in humans: The POMC deficiency syndrome
55. Severe early-onset obesity, adrenal insufficiency, and red hair pigmentation caused by POMC mutations in humans
56. Genetic dissection of complex traits: Guidelines for interpreting and reporting linkage results
57. Interactions between the prohormone convertase 2 promoter and the thyroid hormone receptor
58. Regulation of prohormone convertase 1 (PC1) by thyroid hormone
59. Enzymatic characterization of immunopurified prohormone convertase 2. Potent inhibition by a 7B2 peptide fragment
60. Biosynthesis of precursor corticotropin/endorphin-, corticotropin-, α-melanotropin-, β-lipotropin-, and β-endorphin-like material by cultured neonatal rat hypothalamic neurons
61. Purification and characterization of a paired basic residue-specific proopiomelanocortin converting enzyme from bovine pituitary intermediate lobe secretory vesicles
62. Coexpression of leptin receptor and preproneuropeptide Y mRNA in arcuate nucleus of mouse hypothalamus
63. Hypothalamic agouti-related protein messenger ribonucleic acid is inhibited by leptin and stimulated by fasting
64. Hypothalamic pro-opiomelanocortin mRNA is reduced by fasting and in ob/ob and db/db mice, but is stimulated by leptin
65. Fasting regulates hypothalamic neuropeptide Y. agouti related peptide, and proopiomelanocortin in diabetic mice independent of changes in leptin or insulin
66. Congenital leptin deficiency is associated with severe early-onset obesity in humans
67. Localisation of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain
68. Agouti antagonism of melanocortin-4 receptor: Greater effect with desacetyl-α-melanocyte-stimulating hormone (MSH) than with α-MSH
69. Hyperproinsulinaem in obese fat/fat mice associated with a carboxypeptidase E mutation which reduces enzyme activity
70. Leptin stimulates the expression and biosynthesis of prohormone convertases 1 and 2 (PC1 and PC2) in hypothalamic neurons
71. Evidence that N-acetylation regulates the behavioural activity of alpha-MSH in the rat and human central nervous system
72. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein
73. Brief report: Impaired processing of prohormones associated with abnormalities glucose homeostasis and adrenal function
74. ACTH(1-24) and α-MSH antagonize feeding behaviour stimulated by kappa opiate agonists
75. Central POMC processing in fed/fasted Wistar and lean/obese Zucker rats
76. The C-terminal region of proSAAS is a potent inhibitor of prohormone convertase 1
77. Quantitative expression analysis of genes regulated by both obesity and leptin rveals a regulatory loop between leptin and pituitary-derived ACTH
78. Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function
79. Identification of a receptor for γ melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system
80. The quantitative trait locus on chromosome 2 for serum leptin levels is confirmed in African-Americans
81. Protcolytic processing mechanisms in the biosynthesis of neuroendocrine peptides: The subtilisin-like proprotein convertases
82. Rat and mouse proopiomelanocortin gene sequences target tissues specific expression to the pituitary gland but not to the hypothalamus of transgenic mice
83. Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus
84. Central nervous system control of food intake
85. Obesity and the regulation of energy balance
86. A leptin missense mutation is associated with hypogonadism and morbid obesity
87. Kex-2 like endoproteases PC2 and PC3 accurately cleave a model prohormone in mammalian cells: Evidence for a common core of neuroendocrine processing enzymes
88. Proopiomelanocortin is the predominant adrenocorticotropin-related peptide in human cerebrospinal fluid
89. A frameshift mutation in human MC4R is associated with a dominant form of obesity
90. Glucocorticoid regulation of hypothalamic proopiomelanocortin
91. ACTH precursors: Biological significance and clinical relevance
92. Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin
93. A frameshift mutation in MC4R associated with dominantly inherited human obesity
94. The role of melanocortin signalling in the control of body weight: Evidence from human and murine genetic models
95. Authentic cell-specific and developmentally regulated expression of pro-opiomelanocortin genomic fragments in hypothalamic and hindbrain neurons of transgenic mice
96. Endoproteolytic processing of proopiomelanocortin and prohormone convertases 1 and 2 in neuroendocrine cells overexpressing prohormone convertases 1 or 2